ClinicalTrials.Veeva

Menu

Optimising General Practice Long COVID Care - an Educational Intervention. (GP-COV-ED)

University College Dublin logo

University College Dublin

Status

Not yet enrolling

Conditions

Long COVID

Treatments

Behavioral: Intervention Group

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This trial will evaluate the feasibility of a pilot educational intervention for GPs that aims to enhance care and care outcomes among patients with long COVID at six general practices in the Ireland East region.

Our first objective is to conduct focus groups with key stakeholders (GPs, other health professionals, patients, families/carers) that will inform the contents of an education intervention. The second objective will be to implement this educational intervention, and the third objective will be to determine whether the intervention is feasible.

Study outcomes will include:

  • Qualitative findings from co-design focus groups and post-intervention semi-structured interviews with GPs.
  • Practice and patient study recruitment and retention data.
  • GP / Practice characteristics: age & gender, practice location, general and COVID-19 patient population figures.
  • Patient characteristics: Patient age, gender, COVID-19 vaccination status, and medical history details.
  • Patient scores on a self-report measure assessing the symptoms, symptom severity, functional impact, and overall health (COVID-19 Yorkshire Rehabilitation Scale (C-19-YRS)).

Enrollment

72 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age: Aged 18 years or older at the time of enrolment.

  2. Registration: Are registered as patients at the study's participating practices.

  3. COVID-19 Diagnosis:

    • Previously received a positive COVID-19 PCR or antigen test, or
    • Previously been clinically diagnosed with COVID-19 by a healthcare provider.
  4. Persistent Symptoms:

    o Have spoken with their general practitioner (GP) about experiencing persistent symptoms lasting four weeks or more since their COVID-19 diagnosis.

  5. Consent: Willing and able to provide informed consent to participate in the study.

Exclusion criteria

  1. Vulnerability: Deemed by participating GPs to be a vulnerable individual whose best interests are served by not participating in the study, such as (but not limited to):
  • People with language difficulties that prevent meaningful communication.
  • Individuals with a recognised or diagnosed intellectual, physical, or mental impairment.
  • Older adults considered particularly vulnerable.
  • Individuals residing in institutions (e.g., care homes or prisons).
  • Individuals with an unequal relationship with the researcher(s) (e.g., hierarchical dependence).
  • Members of marginalised or disadvantaged groups for whom participation may present undue burden or risk.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

72 participants in 2 patient groups

Intervention group
Experimental group
Description:
GP practices in the intervention group will be provided with a 'long COVID Toolkit for GPs', they will be invited to attend an long COVID educational webinar, and they will be asked to perform a detailed case review of patients enrolled in the study.
Treatment:
Behavioral: Intervention Group
Control group
No Intervention group
Description:
Control group GPs will be asked to deliver care as usual for patients enrolled in the study.

Trial contacts and locations

0

Loading...

Central trial contact

Walter Cullen, MD; John M Broughan, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems